Molecule retweeted
I said good bye to Dr. Karan Sood at Logan Airport this afternoon as he heads back to Mumbai, India. The time he spent with us at @BrownUniversity and @BrownUnivHealth as a @WINConsortium Precision Oncology Fellow was productive and sets the stage for future work and collaboration. @Dr_R_Kurzrock @SewantiLimaye @LiaTsimberidou @VivekSubbiah @DrChoueiri @TataMemorial
Molecule retweeted
🎉Another successful session of #IASCOMolecule Season 3! Our 14th session on "Drugs in Plasma Cell Neoplasm," with Dr Sumeet Mirgh as Examiner & Dr Faheema Hasan as Speaker received an overwhelming response by participants. Thank you to everyone who had joined.
Molecule retweeted
It was a wonderful discussion
A huge thank you to our incredible faculty @StephenVLiu @LauraAlderMD @TejasPatilMD @g_mountzios @ullas_batra Dr Chandrakanth, Dr Karan Sood for an outstanding #OncoWisdom discussion on What’s New in Lung Cancer from WCLC 2026. 🙏
402 registrations | 160 attendees
Grateful for the time, expertise and honest discussion 🙂.
Thank you for making it special! 🙏
And thank you for all those who attended it . I hope it was useful for all of you 🙂
Molecule retweeted
Team we are SO CLOSE!!! Let’s get this done! @ConquerCancerFd @ASCO @VaniamGroup @DeannavanGestel @UAZCancer
Molecule retweeted
Gentle Reminder to Join us Today at 2 pm for the Hepatopancreaticibilliary & Neuroendocrine Cancer Session of the IASCO Molecule Series
Join us for the next MOLECULE – Chemotherapy Foundations Session on HPB & NET where we dissect chemotherapy concepts with clinical reasoning.
📆12 July 2 PM IST
#Molecule #OncologyFellows #IASCO #Chemotherapy #DM #DrNB #YoungOncologists #MedEd #HPB #NET
📧[email protected] teapawt.org/IASCOMolecule/status/2…
Molecule retweeted
The First 90 Days on the Job: What You Need to Know About Starting Your Oncology Career in Community, Academic, and International Practice Settings | ASCO Connection connection.asco.org/do/first…
@KelseyNatsuhara @ParamMD @ASCOTECAG @ASCO – at Mumbai, India
Molecule retweeted
The ASCO Medical Oncology ITE was more than an exam: it was a learning compass.
In this ASCO Connection piece, I reflect on how formative feedback can reshape training in an Indian context where written exams often dominate.connection.asco.org/do/asco-… @ASCO @ASCOTECAG @oncodaily – at Mumbai, India
Molecule retweeted
Ph2 trial in🇨🇳 (n=100) in unresectable stage III NSCLC: anti–PD-1 induction therapy achieved 61.7% MPR.
⚠️BST1 (AUC 0.78) identified as a predictive biomarker in PD-L1–neg/unevaluable tumors, linked to CD8+/NK infiltration and better EFS/OS (p<0.05)
rdcu.be/emeHn
Molecule retweeted
🎉 Out work from @pmcancercentre is out now in the European Journal of Hematology!
Outcomes of allogeneic transplantation for MDS/MPN overlap neoplasms in the contemporary era 🙌🏽
@Hans_BMTProgram @SergioRdzRdz
onlinelibrary.wiley.com/doi/…
Molecule retweeted
A proud day for the entire Indian oncology community! Dr. Amol Akhade has been selected as a Featured Voice for ASCO 2025. His selfless dedication to mentorship and medical education has shaped academic oncology across the country. Congratulations, Sir @SuyogCancer
Thrilled to announce our Annual Meeting Featured Voices! Get ready for a wealth of expert perspectives and engaging discussions throughout the meeting. Don't miss out – follow along and contribute to the conversation using the official hashtag: #ASCO25
Molecule retweeted
How is Social Media Shaping Oncology Practice and Education? - Karan Sood (@QuantumOnc)
oncodaily.com/blog/karan-soo…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews
Molecule retweeted
🧠 Survey Alert | 5 mins only 🧑⚕️How is Social Media Shaping Oncology Practice & Education? If social media ever helped you learn a drug, a trial, or manage a case—this is for you. 🔗docs.google.com/forms/d/e/1F…
@OncoAlert @OncBrothers @oncodaily @OncLive
@Larvol @brunolarvol @ASCO
Molecule retweeted
We've received 49 responses from oncologists across 5 countries—and the insights are intriguing. Social media is shaping how we learn trials, discuss cases & grow as a community. Help us reach 100. 🧠 Take 5 mins, fill the survey, and share it forward. 🙏 docs.google.com/forms/d/e/1F…




























